Clinical Trials Browser

Phase 1 × Interventional × Neuroendocrine Neoplasms × Clear all

NCT06132113 2026-05-27

DAREON™-7: A Study to Test How Well Different Doses of BI 764532 in Addition to Chemotherapy Are Tolerated by People With Advanced Neuroendocrine Cancers

Phase 1 Recruiting

Neuroendocrine Neoplasms